Technical Analysis for GRTX - Galera Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.13 | -8.63% | -0.01 |
GRTX closed down 8.63 percent on Monday, July 1, 2024, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Sell Signal | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Weak + Overbought | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Weak, Overbought and Reversal Signs | Reversal | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Weak + Overbought | Other | -8.63% | |
Inside Day | Range Contraction | -8.63% |
Alert | Time |
---|---|
Possible NR7 | about 5 hours ago |
Gap Down Closed | about 9 hours ago |
Rose Above Previous Day's High | about 9 hours ago |
60 Minute Opening Range Breakdown | about 9 hours ago |
Down 5% | about 10 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Radiation Radiation Therapy DSL Fibrosis Treatment Of Fibrosis Mucositis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Radiation Radiation Therapy DSL Fibrosis Treatment Of Fibrosis Mucositis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.0899 |
52 Week Low | 0.075 |
Average Volume | 945,563 |
200-Day Moving Average | 0.17 |
50-Day Moving Average | 0.16 |
20-Day Moving Average | 0.11 |
10-Day Moving Average | 0.11 |
Average True Range | 0.02 |
RSI (14) | 47.37 |
ADX | 14.36 |
+DI | 22.44 |
-DI | 20.63 |
Chandelier Exit (Long, 3 ATRs) | 0.17 |
Chandelier Exit (Short, 3 ATRs) | 0.14 |
Upper Bollinger Bands | 0.15 |
Lower Bollinger Band | 0.07 |
Percent B (%b) | 0.69 |
BandWidth | 69.63 |
MACD Line | -0.01 |
MACD Signal Line | -0.02 |
MACD Histogram | 0.0065 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.14 | ||||
Resistance 3 (R3) | 0.14 | 0.14 | 0.14 | ||
Resistance 2 (R2) | 0.14 | 0.13 | 0.14 | 0.14 | |
Resistance 1 (R1) | 0.13 | 0.13 | 0.13 | 0.13 | 0.14 |
Pivot Point | 0.13 | 0.13 | 0.12 | 0.13 | 0.13 |
Support 1 (S1) | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 |
Support 2 (S2) | 0.12 | 0.12 | 0.12 | 0.11 | |
Support 3 (S3) | 0.11 | 0.12 | 0.11 | ||
Support 4 (S4) | 0.11 |